Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidemiology and antimicrobial susceptibility profiles of Enterobacterales causing bloodstream infections before and during COVID-19 pandemic: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2018-2021.
Lee YL, Liu CE, Tang HJ, Huang YT, Chen YS, Hsueh PR; SMART Taiwan Group. Lee YL, et al. J Microbiol Immunol Infect. 2024 Jun;57(3):446-456. doi: 10.1016/j.jmii.2024.04.004. Epub 2024 Apr 7. J Microbiol Immunol Infect. 2024. PMID: 38632023 Free article.
Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Jean SS, Hsueh PR; SMART Asia-Pacific Group. Jean SS, et al. J Antimicrob Chemother. 2017 Jan;72(1):166-171. doi: 10.1093/jac/dkw398. Epub 2016 Oct 4. J Antimicrob Chemother. 2017. PMID: 27703058
Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART).
Sheng WH, Badal RE, Hsueh PR; SMART Program. Sheng WH, et al. Antimicrob Agents Chemother. 2013 Jul;57(7):2981-8. doi: 10.1128/AAC.00971-12. Epub 2013 Apr 15. Antimicrob Agents Chemother. 2013. PMID: 23587958 Free PMC article.
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators. Cohen AT, et al. N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096. N Engl J Med. 2013. PMID: 23388003 Free article. Clinical Trial.
Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
Hsueh PR, Badal RE, Hawser SP, Hoban DJ, Bouchillon SK, Ni Y, Paterson DL; 2008 Asia–Pacific SMART Group. Hsueh PR, et al. Int J Antimicrob Agents. 2010 Nov;36(5):408-14. doi: 10.1016/j.ijantimicag.2010.07.002. Epub 2010 Aug 21. Int J Antimicrob Agents. 2010. PMID: 20728316